ELI LILLY AND COMPANY

Tracked program mentions1

Quoted activity text is clipped to a short extract; each filing’s full description is under Lobbying activities below.

• Making, Maintaining, Supply Chain and Logistics0602025Ematched: “Supply|Chain”matched 2+ title words

  Patient protection; Pharmaceutical supply chain issues and shortages; Drug pricing, coverage, value, access and…

Lobbying activities7

• Copyright/Patent/TrademarkCPT

  Pharmaceutical intellectual property issues

• Consumer Issues/Safety/ProductsCSP

  Multi-lateral threats to IP and the biopharmaceutical industry; Drug importation; Prescription drug value, access and quality

• Health IssuesHCR

  Patient protection; Pharmaceutical supply chain issues and shortages; Drug pricing, coverage, value, access and quality; Transparency; Intellectual property; Health insurance accessibility; Implementation of the "Inflation Reduction Act" (HR.5376); Prescription drug approval; Policy matters related to Artificial Intelligence in health care; One Big Beautiful Bill Act (HR.1)

• Medicare/MedicaidMMM

  Intellectual property; 340B Program; Medicare & Medicaid prescription drug reimbursement pricing, coverage and value; Implementation of the "Inflation Reduction Act" (HR.5376); CMS National Coverage Determination on Alzheimer's disease; One Big Beautiful Bill Act (HR.1)

• PharmacyPHA

  Hospital discounts; 340B program; Prescription drug value, access, quality and compliance with Drug Quality and Safety Act

• Taxation/Internal Revenue CodeTAX

  Implementation and extension of the Tax Cuts and Jobs Act; Domestic manufacturing tax incentives; Expensing of research and development costs; Global minimum tax; Pension and retirement benefit issues; round-tripping; One Big Beautiful Bill Act (HR.1)

• Trade (domestic/foreign)TRD

  Issues related to intellectual property protection and market access within current trade negotiations. Canada IP; USMCA implementation; Mexico patent linkage; Special 301; Trade talks: US-Japan, US-China, US-EU, US-UK, US-India, and US-Brazil; US Tariffs

Lobbyists10

• ASKIA SURUMArevolving door

  Chief of Staff, Rep. Marc Veasey (2017-2021); Deputy Staff Director, Ways and Means Committee (2007-2014); Deputy Staff Director, House Rules Committee (2001-2007); Legislative Director, Rep. Martin Frost (2000-2001)

• DAVID TALBOT
• FRANK DE LIMA
• HEATHER CLARK
• JUAN MACHADOrevolving door

  Senate Finance Committee; Professional Staff and Senior Health Advisor, Department of Health & Human Services, Health Insurance Specialist

• PAUL BURKHEAD
• SARAH KYLErevolving door

  Legislative Asst, Senator Bayh (2007-2011); Legislative Asst, Rep Tim Roemer (2000-2003)

• SHANNON STEHOUWERrevolving door

  Staff, Senator John Hoeven (2014-2016); Staff, Rep. Mike Rogers (2010-2014)

• SHAWN O'NEAIL
• THOMAS ROBERGErevolving door

  Legislative Counsel (2002-2004 - Senator Peter Fitzgerald)